494 related articles for article (PubMed ID: 9045678)
21. Caveolin-1 interacts directly with dynamin-2.
Yao Q; Chen J; Cao H; Orth JD; McCaffery JM; Stan RV; McNiven MA
J Mol Biol; 2005 Apr; 348(2):491-501. PubMed ID: 15811383
[TBL] [Abstract][Full Text] [Related]
22. Evaluating caveolin interactions: do proteins interact with the caveolin scaffolding domain through a widespread aromatic residue-rich motif?
Byrne DP; Dart C; Rigden DJ
PLoS One; 2012; 7(9):e44879. PubMed ID: 23028656
[TBL] [Abstract][Full Text] [Related]
23. Regulated interaction of endothelin B receptor with caveolin-1.
Yamaguchi T; Murata Y; Fujiyoshi Y; Doi T
Eur J Biochem; 2003 Apr; 270(8):1816-27. PubMed ID: 12694195
[TBL] [Abstract][Full Text] [Related]
24. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease.
Lisanti MP; Scherer PE; Vidugiriene J; Tang Z; Hermanowski-Vosatka A; Tu YH; Cook RF; Sargiacomo M
J Cell Biol; 1994 Jul; 126(1):111-26. PubMed ID: 7517942
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain.
Engelman JA; Chu C; Lin A; Jo H; Ikezu T; Okamoto T; Kohtz DS; Lisanti MP
FEBS Lett; 1998 May; 428(3):205-11. PubMed ID: 9654135
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of adenylyl cyclase by caveolin peptides.
Toya Y; Schwencke C; Couet J; Lisanti MP; Ishikawa Y
Endocrinology; 1998 Apr; 139(4):2025-31. PubMed ID: 9528990
[TBL] [Abstract][Full Text] [Related]
27. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14).
Lee H; Woodman SE; Engelman JA; Volonté D; Galbiati F; Kaufman HL; Lublin DM; Lisanti MP
J Biol Chem; 2001 Sep; 276(37):35150-8. PubMed ID: 11451957
[TBL] [Abstract][Full Text] [Related]
28. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity.
Ju H; Zou R; Venema VJ; Venema RC
J Biol Chem; 1997 Jul; 272(30):18522-5. PubMed ID: 9228013
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of PKCalpha and rhoA translocation in differentiated smooth muscle by a caveolin scaffolding domain peptide.
Taggart MJ; Leavis P; Feron O; Morgan KG
Exp Cell Res; 2000 Jul; 258(1):72-81. PubMed ID: 10912789
[TBL] [Abstract][Full Text] [Related]
30. Redistribution of glycolipid raft domain components induces insulin-mimetic signaling in rat adipocytes.
Müller G; Jung C; Wied S; Welte S; Jordan H; Frick W
Mol Cell Biol; 2001 Jul; 21(14):4553-67. PubMed ID: 11416134
[TBL] [Abstract][Full Text] [Related]
31. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling.
Yamamoto M; Toya Y; Jensen RA; Ishikawa Y
Exp Cell Res; 1999 Mar; 247(2):380-8. PubMed ID: 10066366
[TBL] [Abstract][Full Text] [Related]
32. Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation.
Song KS; Sargiacomo M; Galbiati F; Parenti M; Lisanti MP
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):293-303. PubMed ID: 9193783
[TBL] [Abstract][Full Text] [Related]
33. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide.
Oka N; Yamamoto M; Schwencke C; Kawabe J; Ebina T; Ohno S; Couet J; Lisanti MP; Ishikawa Y
J Biol Chem; 1997 Dec; 272(52):33416-21. PubMed ID: 9407137
[TBL] [Abstract][Full Text] [Related]
34. Phospholipase D1 in caveolae: regulation by protein kinase Calpha and caveolin-1.
Kim JH; Han JM; Lee S; Kim Y; Lee TG; Park JB; Lee SD; Suh PG; Ryu SH
Biochemistry; 1999 Mar; 38(12):3763-9. PubMed ID: 10090765
[TBL] [Abstract][Full Text] [Related]
35. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis.
Li S; Song KS; Koh SS; Kikuchi A; Lisanti MP
J Biol Chem; 1996 Nov; 271(45):28647-54. PubMed ID: 8910498
[TBL] [Abstract][Full Text] [Related]
36. Regulation of G protein-coupled receptor kinases by caveolin.
Carman CV; Lisanti MP; Benovic JL
J Biol Chem; 1999 Mar; 274(13):8858-64. PubMed ID: 10085129
[TBL] [Abstract][Full Text] [Related]
37. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin.
Chun M; Liyanage UK; Lisanti MP; Lodish HF
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11728-32. PubMed ID: 7972131
[TBL] [Abstract][Full Text] [Related]
38. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain.
Venema VJ; Ju H; Zou R; Venema RC
J Biol Chem; 1997 Nov; 272(45):28187-90. PubMed ID: 9353265
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes.
Li S; Galbiati F; Volonte D; Sargiacomo M; Engelman JA; Das K; Scherer PE; Lisanti MP
FEBS Lett; 1998 Aug; 434(1-2):127-34. PubMed ID: 9738464
[TBL] [Abstract][Full Text] [Related]
40. Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS.
Arbuzova A; Wang L; Wang J; Hangyás-Mihályné G; Murray D; Honig B; McLaughlin S
Biochemistry; 2000 Aug; 39(33):10330-9. PubMed ID: 10956022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
